Cardiovascular diseases, represented by myocardial infarction and cerebral infarction, are primarily caused by narrowed ...

Compared with dual antiplatelet therapy (DAPT), a de-escalated DAPT strategy resulted in similar graft occlusion rates and ...

Compared with dual antiplatelet therapy (DAPT), a de-escalated DAPT strategy resulted in similar graft occlusion rates and reduced clinically relevant ...

Treating coronary artery disease patients with monotherapy using clopidogrel or ticagrelor is associated with lower rates of future events compared with traditional aspirin, a study has reported. The ...

South Korea: The SMART-CHOICE 3 trial demonstrated that in patients who had completed the standard course of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI), ...

Semaglutide 2.4 mg reduced total cardiovascular events by 22% in people with established cardiovascular disease (CVD) and overweight or obesity without diabetes. 1 Obesity directly leads to ...

With the recent 125th anniversary of aspirin’s discovery, new research is shedding light on innovative approaches to cardiovascular health that can increase access to cardiovascular disease prevention ...

Older millennials, take note: Bayer is worried about your heart health. The drugmaker set out its concerns in an ad for aspirin, showing how people are putting themselves in danger by denying that ...

Some people might reach for a bottle of aspirin to ease pain. But the over-the-counter medication offers more than simply inflammation relief. It may provide heart benefits, too. Indeed, low-dose ...

Many Americans 60 years and older still take aspirin for the primary prevention of cardiovascular disease, even though guidelines have changed. Aspirin can put individuals at an increased risk of ...